ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Japan to cut price of infamously expensive cancer drug again

Government, which already halved Opdivo price, seeks more cost relief

Opdivo has been increasingly popular among cancer patients since its release in 2014 in Japan.

TOKYO -- A cancer drug widely seen as a symbol of exorbitant health care costs is about to get cheaper in Japan, when the health ministry updates government-administered prescription drug prices for next fiscal year.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more